Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

20 Oct 2011 07:00

RNS Number : 5036Q
Xaar PLC
20 October 2011
ย 

๏ปฟ

ย ย 

FOR IMMEDIATE RELEASE

20 October 2011

ย 

ย 

ย 

Xaar plc

ย 

ย 

INTERIM MANAGEMENT STATEMENT AND ANALYST DAY

ย 

ย 

Xaar plc ("Xaar" or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 July 2011.

ย 

Revenue and profit for the third quarter of the year were ahead of the Board's expectations. The Board anticipate that this level of trading will continue during Q4, leading to a strong performance for the full year 2011.

ย 

Sales of Platform 3 ("P3") products in Q3 grew ahead of expectations through the successful completion of the early stages of the capacity expansion programme. This has relieved the short term supply constraint, slightly earlier than anticipated, with the result that P3 revenues are now demand driven. The remaining critical stages of the programme are on track for completion through the fourth quarter of 2011 and the first half of 2012.

ย 

Sales of Platform 1 ("P1") products have performed in line with expectations, with revenue for Q3 2011 slightly lower than Q2 2011, however forward visibility remains limited.

ย 

Royalty income for the year to date has increased compared to the same period last year, reflecting, in part, some market share loss to licensees in markets serviced by P1 products.

ย 

The Group's balance sheet remains strong with net cash at 30 September 2011 of ยฃ16.8 million (30 June 2011 - ยฃ20.6m, 31 December 2010: ยฃ22.0 million). The reduction in net cash reflects planned expenditures related to the capacity expansion.

ย 

To date, the global economic environment has not impacted Xaar's trading. However, the Board remain cautious and continue to monitor sales channels closely.

ย 

Today, Xaar is hosting an open day for analysts at its Huntingdon manufacturing facility. The purpose is to update analysts on progress with the capacity expansion and to discuss the markets for its P3 products. No new information will be presented.

ย 

END

ย 

CONTACTS

ย 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Alex Bevis, Finance Director

Singerย Capitalย Marketsย Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Simon Bloomfield

020-7367-8888 / 07771-758517

ย 

This information is provided by RNS
The company news service from the London Stock Exchange
ย 
END
ย 
ย 
IMSBLBDGGBBBGBC
Date   Source Headline
1st Jul 20221:10 pmRNSTotal Voting Rights
21st Jun 20225:20 pmRNSDirector Declaration - Additional Directorship
1st Jun 202210:22 amRNSTotal Voting Rights
25th May 20221:57 pmRNSResult of AGM
3rd May 20225:20 pmRNSTotal Voting Rights
7th Apr 20226:31 pmRNSPDMR Shareholding
7th Apr 20222:50 pmRNSGrant of Options and Deferred Bonus Share Awards
1st Apr 202210:48 amRNSTotal Voting Rights
29th Mar 20227:00 amRNS2021 Full Year Results
28th Mar 202210:44 amRNSHolding(s) in Company
21st Mar 202212:37 pmRNSNotice of 2021 Preliminary Results
3rd Mar 20227:00 amRNSAcquisition of Megnajet
1st Mar 20225:29 pmRNSTotal Voting Rights
1st Feb 20225:00 pmRNSTotal Voting Rights
18th Jan 20224:35 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Update
4th Jan 20222:39 pmRNSBlock listing Interim Review
4th Jan 20222:37 pmRNSTotal Voting Rights
10th Dec 20214:23 pmRNSGrant of Awards - Replacement
6th Dec 202112:25 pmRNSHolding(s) in Company
1st Dec 20215:00 pmRNSTotal Voting Rights
5th Nov 202110:30 amRNSGrant of Sharesave Options
1st Nov 20214:11 pmRNSCompletion of Divestment of Xaar 3D
1st Nov 20211:56 pmRNSTotal Voting Rights
29th Oct 20214:41 pmRNSSecond Price Monitoring Extn
29th Oct 20214:36 pmRNSPrice Monitoring Extension
25th Oct 202110:38 amRNSResult of General Meeting
15th Oct 202111:50 amRNSGrant of Options and Deferred Bonus Share Awards
14th Oct 20218:44 amRNSBlock Listing Application
13th Oct 20212:52 pmRNSHolding(s) in Company
6th Oct 20212:43 pmRNSPublication of Circular and Notice of GM
6th Oct 20217:00 amRNSProposed divestment of Xaar 3D
1st Oct 202111:59 amRNSTotal Voting Rights
14th Sep 20217:00 amRNS2021 Interim Results
3rd Sep 202112:59 pmRNSNotice of 2021 Interim Results
2nd Sep 20213:40 pmRNSTotal Voting Rights
2nd Aug 20215:02 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSTrading Update
12th Jul 20217:00 amRNSAcquisition of FFEI
1st Jul 20213:20 pmRNSBlock listing Interim Review
1st Jul 202110:51 amRNSTotal Voting Rights
22nd Jun 20215:37 pmRNSHolding(s) in Company
22nd Jun 202111:44 amRNSHolding(s) in Company
16th Jun 20211:17 pmRNSResult of AGM
1st Jun 202110:10 amRNSTotal Voting Rights
17th May 20219:27 amRNSHolding(s) in Company
12th May 202110:15 amRNSHolding(s) in Company
4th May 20213:01 pmRNSTotal Voting Rights
30th Apr 20216:23 pmRNSAnnual Financial Report
27th Apr 20217:00 amRNS2020 FULL YEAR RESULTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.